Shell Asset Management Co. Has $2 Million Stock Position in HCA Healthcare, Inc. $HCA

Shell Asset Management Co. cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 67.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,691 shares of the company’s stock after selling 9,691 shares during the period. Shell Asset Management Co.’s holdings in HCA Healthcare were worth $1,999,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the company. Sovran Advisors LLC increased its stake in shares of HCA Healthcare by 1.0% in the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after buying an additional 22 shares during the period. Centerpoint Advisors LLC raised its holdings in HCA Healthcare by 11.0% during the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares during the last quarter. Hemington Wealth Management boosted its stake in shares of HCA Healthcare by 11.0% in the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock valued at $107,000 after purchasing an additional 25 shares during the last quarter. Abound Wealth Management raised its stake in shares of HCA Healthcare by 28.0% during the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after buying an additional 26 shares during the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC grew its holdings in HCA Healthcare by 17.1% during the 3rd quarter. Annis Gardner Whiting Capital Advisors LLC now owns 185 shares of the company’s stock worth $79,000 after acquiring an additional 27 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Truist Financial upped their price objective on HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Deutsche Bank Aktiengesellschaft increased their target price on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Mizuho set a $540.00 price objective on HCA Healthcare in a research note on Monday, February 2nd. Finally, Raymond James Financial set a $525.00 price target on HCA Healthcare in a report on Monday, October 27th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare Stock Performance

NYSE HCA opened at $539.91 on Friday. The stock has a market capitalization of $120.73 billion, a price-to-earnings ratio of 19.02, a PEG ratio of 1.66 and a beta of 1.36. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $552.90. The stock’s 50 day moving average price is $482.80 and its two-hundred day moving average price is $448.96.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the previous year, the firm posted $6.22 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 13,520 shares of company stock valued at $6,894,067 in the last 90 days. 1.30% of the stock is currently owned by insiders.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.